5324402026-05-182026-05-185324402026-05-185324402026-05-182026-05-185324402026-05-18MPSLTDMPS LIMITEDNewDividend2026-05-18true2026-05-082026-05-1510:30:0013:55:00NoThe Company's cash flow during the year was deployed towards the acquisition of Unbound Medicine, Inc. which was completed on 9 February 2026. The capital is being retained to support the Company's growth. This is consistent with the Company's longstanding capital allocation framework, under which capital is returned to shareholders when deployment opportunities at the Company's return thresholds are not available within a twelve-month horizon. Hence, the Board of Directors has decided not to recommend a final dividend for the financial year 2025-26.